Human GTSE1/B99 ORF/cDNA clone-Lentivirus plasmid (NM_016426)

Cat. No.: pGMLP001658
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human GTSE1/B99 Lentiviral expression plasmid for GTSE1 lentivirus packaging, GTSE1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.

Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.


Target products collection

Go to GTSE1/B99 products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Total Price: $1054.8
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMLP001658
Gene Name GTSE1
Accession Number NM_016426
Gene ID 51512
Species Human
Product Type Lentivirus plasmid (overexpression)
Insert Length 2220 bp
Gene Alias B99
Fluorescent Reporter ZsGreen
Mammalian Cell Selection Puromyocin
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGAAGGAGGCGGCGGCCGCGATGAGCCTTCAGCCTGCCGGGCAGGGGACGTGAACATGGATGACCCTAAGAAGGAAGACATTCTTCTTTTGGCCGATGAAAAATTTGACTTCGATCTTTCATTGTCTTCTTCGAGTGCAAATGAAGATGATGAAGTCTTCTTCGGACCCTTTGGACATAAAGAAAGATGTATTGCTGCCAGCTTGGAATTAAATAATCCGGTTCCCGAACAGCCTCCGTTGCCCACATCTGAGAGTCCCTTTGCCTGGAGCCCTCTGGCCGGGGAGAAGTTCGTGGAGGTGTACAAAGAAGCTCACTTACTGGCTTTACACATTGAGAGCAGCAGCCGGAACCAGGCAGCCCAAGCTGCCAAGCCTGAAGACCCTCGGAGCCAGGGCGTGGAAAGATTCATACAGGAGTCAAAATTAAAAATAAACCTCTTTGAGAAAGAAAAGGAAATGAAGAAAAGCCCCACGTCTCTTAAAAGGGAGACATACTACCTGTCAGACAGCCCCTTGCTGGGGCCCCCTGTGGGTGAGCCTCGGCTCTTGGCCTCCTCCCCGGCCCTGCCCAGCTCTGGTGCCCAGGCCCGCCTCACCCGGGCGCCGGGGCCTCCGCACTCTGCTCATGCTTTGCCCAGGGAATCATGCACTGCTCATGCTGCAAGTCAGGCAGCGACTCAGAGGAAGCCCGGGACCAAATTGCTGCTGCCTCGAGCGGCCTCTGTTAGAGGAAGAAGCATCCCTGGGGCTGCGGAGAAGCCCAAGAAAGAGATTCCAGCTAGTCCTTCCAGGACAAAAATCCCAGCTGAGAAGGAATCCCACCGGGATGTTCTCCCTGACAAACCTGCCCCGGGTGCTGTCAATGTGCCGGCCGCCGGAAGCCACTTGGGCCAGGGCAAGCGGGCGATCCCTGTTCCAAACAAGTTGGGGCTGAAGAAGACCCTGTTAAAAGCACCCGGCTCTACCAGCAATCTCGCAAGGAAGTCCTCCTCGGGGCCTGTTTGGAGCGGGGCATCCAGTGCGTGCACATCCCCAGCAGTGGGCAAAGCTAAATCAAGTGAATTTGCAAGTATTCCTGCAAATAGCTCCCGGCCTCTGTCAAACATCAGCAAGTCAGGCAGAATGGGACCCGCCATGCTGCGGCCAGCTCTGCCTGCAGGCCCTGTGGGGGCATCCTCCTGGCAGGCCAAGCGGGTCGATGTTTCTGAGCTGGCAGCGGAGCAGCTCACGGCACCCCCCTCAGCATCCCCCACCCAACCCCAGACTCCGGAAGGTGGCGGCCAGTGGCTGAACTCCAGTTGCGCTTGGTCAGAATCTTCTCAATTGAATAAGACTAGAAGTATCAGACGGCGAGATTCCTGTCTAAATTCCAAGACAAAGGTTATGCCTACTCCTACAAATCAATTTAAAATTCCTAAGTTTTCTATTGGTGACTCCCCGGACAGCTCAACACCAAAGCTTTCGCGGGCACAGCGGCCGCAGTCGTGCACGTCAGTTGGCAGGGTCACTGTCCACAGCACCCCGGTTAGACGCTCATCTGGGCCAGCACCACAAAGCCTGCTGAGCGCATGGCGTGTGTCAGCCTTGCCCACACCCGCCAGCCGGCGCTGCTCTGGCCTTCCACCGATGACCCCCAAAACGATGCCCAGGGCCGTGGGCTCTCCCCTGTGTGTGCCAGCTCGGAGACGTTCCTCTGAGCCCCGCAAGAACTCTGCAATGAGAACTGAACCAACAAGGGAGAGCAACAGAAAGACAGATTCCAGGCTGGTGGATGTGTCCCCTGACAGGGGTTCTCCTCCTTCCCGTGTGCCTCAGGCACTTAACTTTTCTCCAGAGGAAAGCGATTCTACTTTCTCCAAAAGTACTGCCACAGAAGTAGCTCGGGAGGAAGCCAAGCCGGGTGGAGATGCAGCCCCTAGTGAGGCTCTTCTTGTAGATATCAAACTGGAACCACTCGCGGTCACTCCAGATGCTGCAAGCCAGCCCCTCATTGACCTTCCTCTCATCGACTTCTGCGATACCCCAGAAGCACACGTGGCTGTAGGATCTGAAAGCAGGCCTCTGATCGACCTCATGACAAACACTCCAGACATGAATAAAAATGTGGCCAAACCTTCACCGGTGGTGGGACAGCTCATAGACCTGAGCTCCCCTCTGATCCAGCTGAGCCCTGAGGCTGACAAGGAGAACGTGGATTCCCCACTCCTCAAGTTCTAA
ORF Protein Sequence MEGGGGRDEPSACRAGDVNMDDPKKEDILLLADEKFDFDLSLSSSSANEDDEVFFGPFGHKERCIAASLELNNPVPEQPPLPTSESPFAWSPLAGEKFVEVYKEAHLLALHIESSSRNQAAQAAKPEDPRSQGVERFIQESKLKINLFEKEKEMKKSPTSLKRETYYLSDSPLLGPPVGEPRLLASSPALPSSGAQARLTRAPGPPHSAHALPRESCTAHAASQAATQRKPGTKLLLPRAASVRGRSIPGAAEKPKKEIPASPSRTKIPAEKESHRDVLPDKPAPGAVNVPAAGSHLGQGKRAIPVPNKLGLKKTLLKAPGSTSNLARKSSSGPVWSGASSACTSPAVGKAKSSEFASIPANSSRPLSNISKSGRMGPAMLRPALPAGPVGASSWQAKRVDVSELAAEQLTAPPSASPTQPQTPEGGGQWLNSSCAWSESSQLNKTRSIRRRDSCLNSKTKVMPTPTNQFKIPKFSIGDSPDSSTPKLSRAQRPQSCTSVGRVTVHSTPVRRSSGPAPQSLLSAWRVSALPTPASRRCSGLPPMTPKTMPRAVGSPLCVPARRRSSEPRKNSAMRTEPTRESNRKTDSRLVDVSPDRGSPPSRVPQALNFSPEESDSTFSKSTATEVAREEAKPGGDAAPSEALLVDIKLEPLAVTPDAASQPLIDLPLIDFCDTPEAHVAVGSESRPLIDLMTNTPDMNKNVAKPSPVVGQLIDLSSPLIQLSPEADKENVDSPLLKF

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-IP2534-Ab Anti-GTSE1 monoclonal antibody
    Target Antigen GM-Tg-g-IP2534-Ag GTSE1 protein
    ORF Viral Vector pGMLP001658 Human GTSE1 Lentivirus plasmid
    ORF Viral Vector vGMLP001658 Human GTSE1 Lentivirus particle


    Target information

    Target ID GM-IP2534
    Target Name GTSE1
    Gene ID 51512, 29870, 714207, 300126, 101097327, 608855, 507901, 100053362
    Gene Symbol and Synonyms B99,Gtse-1,GTSE1,RGD1563164
    Uniprot Accession Q9NYZ3
    Uniprot Entry Name GTSE1_HUMAN
    Protein Sub-location Introcelluar Protein
    Category Not Available
    Disease Not Available
    Gene Ensembl ENSG00000075218
    Target Classification Not Available

    The protein encoded by this gene is only expressed in the S and G2 phases of the cell cycle, where it colocalizes with cytoplasmic tubulin and microtubules. In response to DNA damage, the encoded protein accumulates in the nucleus and binds the tumor suppressor protein p53, shuttling it out of the nucleus and repressing its ability to induce apoptosis. [provided by RefSeq, Jul 2008]



    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.